Sclerosis News and Research

RSS

New weapon for asthmatics to combat winter asthma attacks

A British team from the University of Southampton, led by the world-acknowledged asthma experts, Professor Stephen Holgate and Professor Donna Davies, has identified a therapy used to treat multiple sclerosis (MS) as a potential novel treatment to reduce asthma attacks caused by the common cold virus.

23 Mar 2005

Sunlight prevents cancer

The health of the public is being put at risk by recommendations to cover up and stay out of the sun in the UK. These recommendations, which are part of Cancer Research UK’s SunSmart programme, increase the risk of several types of cancer, and may also increase deaths from melanoma, the most serious form of skin cancer.

23 Mar 2005

Scientists have found genetic regions that, when defective, allow the immune system to attack the pancreas

Scientists at Joslin Diabetes Center have found genetic regions that, when defective, allow the immune system to attack the pancreas -- the first in a series of mis-steps that lead to type 1 diabetes. Armed with these findings, published yesterday, March 22, in the journal Immunity, the researchers are now trying to hone in on the exact genes involved, in mice and in human patients.

23 Mar 2005

Sixteen per cent of people who use cannabis for medical reasons say that their doctor suggested it

"The results of our UK survey, including the extent of use and reported effects, lend support to the further development of safe and effective medicines based on cannabis" says lead author Dr Mark Ware principal investigator and pain physician at the McGill University Health Centre (MUHC) Pain Centre.

21 Mar 2005

Major milestone in identifying and creating a register of genes involved in multiple sclerosis

For the first time in this disease area, researchers at the SGI have identified 80 genes involved in the inflammatory and neuro-degenerative pathways of MS, based on a 40% genome scan comparing the genetic profile of a total of 1,800 people with MS and healthy individuals in different populations.

17 Mar 2005

Doctors may soon be able to diagnose multiple sclerosis (MS) with a simple blood test

New research by Wake Forest University Baptist Medical Center and colleagues suggests that one day, doctors may be able to diagnose multiple sclerosis (MS) with a simple blood test. The findings are reported in the current issue of the Journal of Molecular Neuroscience.

15 Mar 2005

Gene therapy helps Lou Gehrig's disease

The most common form of motor neurone disease, called amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease, is caused when neurones in the spinal cord die, leading to muscle wasting and total paralysis.

14 Mar 2005

New twist on the role that estrogens play in the development of behavioral differences between men and women

What makes a man behave like a man and a woman a woman? The answer may be partly in your genes. Researchers at the University of Virginia Health System have discovered a new twist on the role that estrogens play in the development of behavioral differences between males and females.

14 Mar 2005

RNA interference as promising therapy for ALS

Scientists at the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have used RNA interference in transgenic mice to silence a mutated gene that causes inherited cases of amytrophic lateral sclerosis (ALS), substantially delaying both the onset and the progression rate of the fatal motor neuron disease.

13 Mar 2005

New MS drug withdrawn from the market

Two patients involved in clinical trials of Tysabri, have contracted a rare and fatal disease, Elan’s multiple sclerosis (MS); one has already died. Withdrawal of the drug, eliminates all hope that it will be allowed back on the market this year, or ever.

8 Mar 2005

Neuren and Metabolic collaborate to develop range of nerve repair compounds

Neuren Pharmaceuticals Ltd (Neuren) and Metabolic Pharmaceuticals Ltd (Metabolic) have announced that the two companies have agreed to collaborate to co-develop Neuren's class of Neuro-regenerative Peptides (NRPs) for the treatment of degenerative conditions such as peripheral neuropathy, motor neuron disease and repairing the brain or nerves after injuries such as spinal cord injury.

7 Mar 2005

FDA wants full authority to control labeling for drugs

Sandra L. Kweder, FDA's deputy director for new drugs, wants Congress to issue the FDA with the authority to control labeling for drugs to stop the prolonged disputes on this matter.

2 Mar 2005

Mathematical model describes the electrical storm that rages during a brain seizure

"We're trying to get to the underlying state of the brain that leads to these seizures," said Mark Kramer, a Ph.D. student in UC Berkeley's Applied Science and Technology Program and lead author of the paper. "Our hope is that the model can highlight potential areas where a seizure can be stopped."

24 Feb 2005

Discovery could lead to the prevention, and possibly treatment of autoimmune diseases such as Type 1 diabetes

Scientists at the University of Maryland School of Medicine in Baltimore have identified a way to prevent Type I diabetes in rats that are genetically prone to develop the disease.

23 Feb 2005

Exercise therapy can improve muscle strength in people with multiple sclerosis

Exercise therapy also improved the mood of MS patients in exercise therapy programs, compared to patients who did not participate in the therapy. The researchers did not find any evidence that exercise therapy affected patients’ fatigue or their sense of how ill they were.

22 Feb 2005

Renovis announces investigational medicine for multiple sclerosis study

Renovis announced today the initiation of a Phase Ia clinical trial for REN-850, an investigational oral small molecule that is being targeted for the treatment of multiple sclerosis (MS).

14 Feb 2005

Finding points towards the possibility of retrovirus involvement in ALS (amyotrophic lateral sclerosis)

A significant proportion of patients suffering from ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease or motor neuron disease, have a marker of retrovirus activity in their blood, reports the February 8 issue of the medical journal Neurology.

7 Feb 2005

Sclerosis News and Research

New weapon for asthmatics to combat winter asthma attacks

Sunlight prevents cancer

Scientists have found genetic regions that, when defective, allow the immune system to attack the pancreas

Sixteen per cent of people who use cannabis for medical reasons say that their doctor suggested it

Major milestone in identifying and creating a register of genes involved in multiple sclerosis

Doctors may soon be able to diagnose multiple sclerosis (MS) with a simple blood test

Gene therapy helps Lou Gehrig's disease

New twist on the role that estrogens play in the development of behavioral differences between men and women

RNA interference as promising therapy for ALS

New MS drug withdrawn from the market

Neuren and Metabolic collaborate to develop range of nerve repair compounds

FDA wants full authority to control labeling for drugs

Mathematical model describes the electrical storm that rages during a brain seizure

Discovery could lead to the prevention, and possibly treatment of autoimmune diseases such as Type 1 diabetes

Exercise therapy can improve muscle strength in people with multiple sclerosis

Renovis announces investigational medicine for multiple sclerosis study

Finding points towards the possibility of retrovirus involvement in ALS (amyotrophic lateral sclerosis)

Scientists have coaxed human embryonic stem cells to become spinal motor neurons

Exposure to infant siblings decreases multiple sclerosis risk

Antioxidants do not prolong the survival of patients with amyotrophic lateral sclerosis, or Lou Gehrig’s disease

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News